Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The safety and relative effectiveness of non-psychoactive cannabinoid formulations for the improvement of sleep: a double-blinded, randomized controlled trial

View ORCID ProfileJessica Londeree Saleska, Corey Bryant, Antonija Kolobaric, Christopher S. Colwell, Derek Loewy, Jeff Chen, Emily K. Pauli
doi: https://doi.org/10.1101/2023.01.20.23284842
Jessica Londeree Saleska
1Radicle Science, 3456 Fortuna Ranch Rd., Encinitas CA, 92024
PhD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jessica Londeree Saleska
  • For correspondence: jessica{at}radiclescience.com
Corey Bryant
1Radicle Science, 3456 Fortuna Ranch Rd., Encinitas CA, 92024
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonija Kolobaric
2Center for Neuroscience, University of Pittsburgh, A210 Langley Hall, Pittsburgh, PA 15260
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher S. Colwell
3Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, 760 Westwood Plaza, Los Angeles, CA 90095
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek Loewy
4Scripps Clinic Sleep Center, 10666 N Torrey Pines Rd #2, San Diego, CA 92037
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeff Chen
1Radicle Science, 3456 Fortuna Ranch Rd., Encinitas CA, 92024
MD, MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily K. Pauli
1Radicle Science, 3456 Fortuna Ranch Rd., Encinitas CA, 92024
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: January 2023 to May 2025

AbstractFullPdf
Jan 20233611297
Feb 20232471489105
Mar 2023210190168
Apr 2023160134076
May 20237885646
Jun 2023608631
Jul 2023337127
Aug 20233811833
Sep 2023708824
Oct 2023507023
Nov 2023577219
Dec 2023654720
Jan 2024583724
Feb 2024804120
Mar 2024583431
Apr 20246410228
May 20242912827
Jun 20244212828
Jul 2024417423
Aug 2024332819
Sep 2024503628
Oct 2024562531
Nov 2024512433
Dec 2024463721
Jan 2025318823
Feb 20253710620
Mar 20255310920
Apr 20255733424
May 20256225616
Back to top
PreviousNext
Posted January 23, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The safety and relative effectiveness of non-psychoactive cannabinoid formulations for the improvement of sleep: a double-blinded, randomized controlled trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The safety and relative effectiveness of non-psychoactive cannabinoid formulations for the improvement of sleep: a double-blinded, randomized controlled trial
Jessica Londeree Saleska, Corey Bryant, Antonija Kolobaric, Christopher S. Colwell, Derek Loewy, Jeff Chen, Emily K. Pauli
medRxiv 2023.01.20.23284842; doi: https://doi.org/10.1101/2023.01.20.23284842
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The safety and relative effectiveness of non-psychoactive cannabinoid formulations for the improvement of sleep: a double-blinded, randomized controlled trial
Jessica Londeree Saleska, Corey Bryant, Antonija Kolobaric, Christopher S. Colwell, Derek Loewy, Jeff Chen, Emily K. Pauli
medRxiv 2023.01.20.23284842; doi: https://doi.org/10.1101/2023.01.20.23284842

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pharmacology and Therapeutics
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (758)
  • Anesthesia (222)
  • Cardiovascular Medicine (3312)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13397)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5174)
  • Geriatric Medicine (482)
  • Health Economics (785)
  • Health Informatics (3283)
  • Health Policy (1145)
  • Health Systems and Quality Improvement (1198)
  • Hematology (432)
  • HIV/AIDS (1022)
  • Infectious Diseases (except HIV/AIDS) (14650)
  • Intensive Care and Critical Care Medicine (914)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (525)
  • Neurology (4949)
  • Nursing (262)
  • Nutrition (734)
  • Obstetrics and Gynecology (888)
  • Occupational and Environmental Health (797)
  • Oncology (2530)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1305)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (558)
  • Psychiatry and Clinical Psychology (4223)
  • Public and Global Health (7525)
  • Radiology and Imaging (1713)
  • Rehabilitation Medicine and Physical Therapy (1018)
  • Respiratory Medicine (981)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (72)
  • Transplantation (237)
  • Urology (206)